DEA considers re-scheduling cannabis

The DEA has been swiping left on cannabis for years by Amber Cann, PharmD, MBA, MSc

But they may soon be ready to set up a date

Read on Substack
Previous
Previous

Opioid-related deaths likely to decline among Kentucky’s medical cannabis patients

Next
Next

The ABCs of Cannabinoids